Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 11,173-11,184 of 23,847

OngoingEUCTR 2022-000054-28

Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (OligoTreat)

This summary needs review. Please check the official study record and contact the research team for details.

In Germany

SchizophreniaOther

Countries: Germany
Sponsor: Klinikum der Universität München
Condition: Schizophrenia

View study

CompletedNCT05267873

Combining Data Sources to Identify Effect Moderation for Personalized Mental Health

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

In Baltimore

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Johns Hopkins Bloomberg School of Public Health
Condition: Depression

View study

CompletedNCT06795659

Combining Esketamine and Prolonged Exposure Treatment for PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In San Antonio

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: The University of Texas Health Science Center at San Antonio
Condition: PTSD

View study

Enrolling By InvitationNCT07680959

Combining HD-tDCS and iTBS in Treating Negative Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Taipei

SchizophreniaBehavioralFrom 18 Years to 65 Years

Countries: Taiwan
Sponsor: Tri-Service General Hospital (TSGH)
Condition: Schizophrenia

View study

TerminatedNCT04495673

Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis

AddictionBehavioralFrom 18 Years to 60 Years

Countries: United States
Sponsor: University of Minnesota
Condition: Addiction

View study

WithdrawnNCT02570763

Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

AddictionDeviceFrom 18 Years to 65 Years

Countries
Sponsor: University of Minnesota
Condition: Addiction

View study

CompletedNCT03048643

Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis

This summary needs review. Please check the official study record and contact the research team for details.

In Lexington

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Laura Fanucchi
Condition: Addiction

View study

TerminatedNCT06500533

Combining rTMS and tDCS in Depression: an Exploratory study

This summary needs review. Please check the official study record and contact the research team for details.

In Herning

DepressionDeviceFrom 22 Years to 80 Years

Countries: Denmark
Sponsor: Regionspsykiatrien Gødstrup
Condition: Depression

View study

WithdrawnNCT03497299

Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

Location not clearly listed

Schizophrenia, AddictionDeviceFrom 18 Years to 55 Years

Countries
Sponsor: Centre for Addiction and Mental Health
Condition: Schizophrenia, Addiction

View study

CompletedNCT02698215

Combining Varenicline and Naltrexone for Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Addiction

View study

OngoingEUCTR 2011-004692-36

COMBIVAR. study of two parallel groups design efficacy of smoking cessation with combined (varenicline plus nicotine patches) versus monotherapy (varenicline)

This study is ongoing in Spain. It focuses on Addiction.

In Spain

AddictionOther

Countries: Spain
Sponsor: HOSPITAL UNIVERSITARI DE BELLVITGE
Condition: Addiction

View study

CompletedNCT02354183

Commitment and Motivation in a Brief DBT Intervention for Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto

SuicidalityBehavioralFrom 18 Years to 80 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Suicidality

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.